Skip to main content

PROTEINAS DE MEMBRANA: DE LOS PRINCIPIOS BASICOS AL SARS-COV-2

PID2020-119111GB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2020
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSITAT DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

Identification of small molecules with virus growth enhancement properties

  • García-Murria, Maria Jesús
  • Gadea-Salom, Laura
  • Moreno, Sandra
  • Zaragoza, Óscar
  • Brun Torres, Alejandro
  • Mingarro, Ismael
  • Martínez-Gil, Luis
The novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused the pandemic disease known as coronavirus disease 2019 (COVID-19). COVID-19 vaccines were developed at record speed and were authorized approximately a year after the original outbreak. This fast response saved the lives of countless individuals and reduced the disease burden of many more. The experience has served as a reminder of the necessity to implement solid vaccine development platforms and fast production pipelines. Manufacturing vaccines for enveloped viruses, including some SARS-CoV-2 vaccines, often relies on the production of large quantities of viruses in vitro. Thus, speeding up or increasing virus production would expedite vaccine development. With this objective in mind, we established a high throughput screening (HTS) to identify small molecules that enhance or speed up host-virus membrane fusion. Among the HTS hits, we identified that ethynylestradiol augments SARS-CoV-2 fusion activity in both the absence and presence of TMPRSS2. Furthermore, we confirmed that ethynylestradiol can boost the growth of not only SARS-CoV-2 but also Influenza A virus in vitro. A small molecule with these characteristics could be implemented to improve vaccines production., We thank the Generalitat Valenciana (PROMETEO/2019/065) and the Spanish Ministry of Science and Innovation (PID2020-119111GB-I00). We thank P. Selvi for excellent technical assistance. O.Z. is funded by grant PID2020-114546RB-I00 from National Research Agency (Spanish Ministry for Science and Innovation). This publication was also supported by the European Virus Archive GLOBAL (EVA-GLOBAL) project which has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement 871029., No
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Identification of small molecules capable of enhancing viral membrane fusion

  • García-Murria, Maria Jesús
  • Gadea-Salom, Laura
  • Moreno, Sandra
  • Rius-Salvador, Marina
  • Zaragoza, Óscar
  • Brun Torres, Alejandro
  • Mingarro, Ismael
  • Martínez-Gil, Luis
12 Pág., Several approaches have been developed to analyze the entry of highly pathogenic viruses. In this study, we report the implementation of a Bimolecular Multicellular Complementation (BiMuC) assay to safely and efficiently monitor SARS-CoV-2 S-mediated membrane fusion without the need for microscopy-based equipment. Using BiMuC, we screened a library of approved drugs and identified compounds that enhance S protein-mediated cell-cell membrane fusion. Among them, ethynylestradiol promotes the growth of SARS-CoV-2 and Influenza A virus in vitro. Our findings demonstrate the potential of BiMuC for identifying small molecules that modulate the life cycle of enveloped viruses, including SARS-CoV-2., This work was supported by the Generalitat Valenciana (PROMETEO/2019/065) and grant PID2020-119111GB-I00 by MCIN/AEI/10.13039/501100011033. O.Z. is funded by grant PID2020-114546RB by MCIN/AEI/10.13039/501100011033. L.G. is the recipient of a predoctoral contract (CIACIF/2021/119) from the Generatitat Valenciana. M.R-S is the recipient of a predoctoral contract from the Spanish Ministry of Science and Innovation (PRE2021-101042 by MCIN/AEI/10.13039/501100011033). This publication was also supported by the European Virus Archive GLOBAL (EVA-GLOBAL) project which has received funding from the European Union?s Horizon 2020 research and innovation program under grant agreement 871029., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cetylpyridinium chloride and chlorhexidine show antiviral activity against Influenza A virus and Respiratory Syncytial virus in vitro

  • Rius-Salvador, Marina
  • García-Múrria, Maria Jesús
  • Rusu, Luciana
  • Bañó-Polo, Manuel
  • León, Rubén
  • Geller, Ron
  • Mingarro, Ismael
  • Martinez-Gil, Luis
[Background]: The oral cavity is the site of entry and replication for many respiratory viruses. Furthermore, it is the source of droplets and aerosols that facilitate viral transmission. It is thought that appropriate oral hygiene that alters viral infectivity might reduce the spread of respiratory viruses and contribute to infection control., [Materials and methods]: Here, we analyzed the antiviral activity of cetylpyridinium chloride (CPC), chlorhexidine (CHX), and three commercial CPC and CHX-containing mouthwash preparations against the Influenza A virus and the Respiratory syncytial virus. To do so the aforementioned compounds and preparations were incubated with the Influenza A virus or with the Respiratory syncytial virus. Next, we analyzed the viability of the treated viral particles., [Results]: Our results indicate that CPC and CHX decrease the infectivity of both the Influenza A virus and the Respiratory Syncytial virus in vitro between 90 and 99.9% depending on the concentration. Likewise, CPC and CHX-containing mouthwash preparations were up to 99.99% effective in decreasing the viral viability of both the Influenza A virus and the Respiratory syncytial virus in vitro., [Conclusion]: The use of a mouthwash containing CPC or CHX alone or in combination might represent a cost-effective measure to limit infection and spread of enveloped respiratory viruses infecting the oral cavity, aiding in reducing viral transmission. Our findings may stimulate future clinical studies to evaluate the effects of CPC and CHX in reducing viral respiratory transmissions., DENTAID partially funded this study and supplied mouthwash formulations. This work was supported by the Generalitat Valenciana (PROMETEO/2022/062) and grant PID2020-119111GB-I00 by MCIN/AEI/10.13039/501100011033. R.G. acknowledges funding from the European Commission – NextGenerationEU (Regulation EU 2020/2094), through the CSIC's Global Health Platform (PTI Salud Global). M.R-S is the recipient of a predoctoral contract from the Spanish Ministry of Science and Innovation (PRE2021-101042 by MCIN/AEI/10.13039/501100011033)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Otros (Other)

The sequence and structural integrity of the SARS-CoV-2 Spike protein transmembrane domain is crucial for viral entry

  • Ortiz-Mateu, Juan
  • Belda, Diego
  • Avilés-Alía, Ana Isabel
  • Alonso-Romero, Josep
  • García-Múrria, Maria Jesús
  • Mingarro, Ismael
  • Geller, Ron
  • Martinez-Gil, Luis
The Spike protein of SARS-CoV-2 is a type I membrane protein that mediates target cell recognition and membrane fusion. Its transmembrane domain (TMD) is usually considered a passive physical anchor that attaches the protein to the viral envelope. However, current knowledge of the dynamics and biogenesis of integral membrane proteins indicates that TMDs generally play key functions beyond membrane anchoring. Here, we explored the role of the SARS-CoV-2 Spike protein TMD during viral entry. To do so, we generated a series of amino acid substitutions and insertions within the hydrophobic core of the TMD and analyzed their impact on protein function. Our results indicate that the SARS-CoV-2 Spike protein is highly susceptible to changes in its TMD. Furthermore, the TMD sequence and structural parameters relevant for viral entry are distributed across the entire segment, albeit with a stronger implication of the N-terminal portion. The relative orientation of the regions before and after the TMD was also found to be relevant for particle entry. Finally, our results suggest that the SARS-CoV-2 Spike protein TMD can form homo-oligomers through a motif in which small residues are necessary., We thank P. Selvi and S. Pinto for their excellent technical assistance and V. Febrer for reviewing the manuscript. This work was supported by the Generalitat Valenciana (CIPROM/2022/62) and grant PID2020-119111GB-I00, PID2023-152568NB-I00 and CNS2022-135100 by MCIN/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR. J. O-M. has a predoctoral contract granted by the Universisty of Valencia’s “Atracció de Talent” programme (UV501 INV_PREDOC 1911519). D. B. had a research contract funded by CIPROM/2022/62 project. Flow Cytometry experiments were carried out in the Cell Culture and Flow Cytometry facility at the SCSIE (University of Valencia)., No